{{Rsnum
|rsid=5750250
|Gene=MYH9
|Chromosome=22
|position=36312438
|Orientation=plus
|GMAF=0.1529
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=MYH9
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 88.5 | 11.5 | 0.0
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 12.9 | 49.0 | 38.1
| ASW | 25.0 | 64.3 | 10.7
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 98.0 | 2.0 | 0.0
| LWK | 11.9 | 66.1 | 22.0
| MEX | 81.0 | 19.0 | 0.0
| MKK | 30.8 | 49.4 | 19.9
| TSI | 82.4 | 17.6 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20635188
|Title=Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene
|OA=1
}}

{{PMID Auto
|PMID=20124285
|Title=Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15
|OA=1
}}

{{PMID Auto
|PMID=20144966
|Title=African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans.
|OA=1
}}

{{PMID Auto
|PMID=20634883
|Title=Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in Africa.
|OA=1
}}

{{PMID Auto
|PMID=22956460
|Title=Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}